Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kyverna Therapeutics (NASDAQ:KYTX) through any online brokerage.
Other companies in Kyverna Therapeutics’s space includes: Tectonic Therapeutic Inc (NASDAQ:TECX), Galectin Therapeutics Inc (NASDAQ:GALT), Immuneering Corp (NASDAQ:IMRX), Larimar Therapeutics Inc (NASDAQ:LRMR) and PepGen Inc (NASDAQ:PEPG).
Kyverna Therapeutics has a consensus price target of $21.17.
The stock price for Kyverna Therapeutics (NASDAQ: KYTX) is $9.71 last updated December 15, 2025 at 4:16 PM EST.
There are no upcoming dividends for Kyverna Therapeutics.
Kyverna Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Kyverna Therapeutics.
Kyverna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.